LRP5 and breast cancer: Osteocyte-specific LRP5 overexpression endows osteocytes with tumor-suppressive properties, resulting in the secretion of conditioned medium (CM) enriched in factors that inhibit breast cancer cell proliferation and metastasis [15,16].